Morgan Stanley raised the firm’s price target on Emerson (EMR) to $125 from $115 and keeps an Underweight rating on the shares as the analyst is updating estimates ahead of earnings.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: